MORGAN MADDOX: Open Payments
NPI 1275297780 · DULLES, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 27 payments from 8 companies in 2025. Trend: 2023 $239 · 2024 $342 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $165 |
| SCPHARMACEUTICALS INC. | 5 | $127 |
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| PFIZER INC. | 4 | $78 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Boston Scientific Corporation | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: REPATHA, FUROSCIX, LEQVIO, VYNDAQEL, VERQUVO, WATCHMAN Access System, ENTRESTO, CAMZYOS.
Industry payments across VA — which companies pay providers there.
